Home|Journals|Articles by Year|Audio Abstracts
 

Original Article



A simple approach to generate transgenic cell lines with high efficiency using CRISPR and flippase-mediated recombination

Sudipta Sarma, Rohan Kamat, Shiny C. Thomas.




Abstract

Clustered regularly interspaced short palindromic repeats (CRISPR) can be concocted to cleave any desired sequence in the genome. We combine its precision with the efficiency of flippase based homologous recombination (HR) to insert genes at a safe genomic locus like Adeno-associated virus integration site 1 (AAVS1) in seven different cell lines. Our approach involves the creation of an acceptor cell line tagged with flippase recognition target (FRT), which accelerates the generation of the desired transgenic cell line with a single-copy insertion at a specific locus. To create this acceptor cell line, we designed a series of guide RNAs (gRNAs) that recognize and cleave a specific sequence within the AAVS1 locus. These validated gRNAs were co-expressed with an FRT-tagging plasmid, which expresses reporter genes (fluorescence and/or antibiotic resistance) flanked by FRT-recombination and genomic sequences adjacent to the CRISPR site. This process resulted in the generation of an acceptor cell line tagged with FRT and reporter genes, using CRISPR-induced HR. Subsequently, a donor plasmid containing mCherry (our gene of interest/GOI) and reporter genes flanked by FRT was introduced into the acceptor cell line. This led to the insertion of the GOI and reporter genes in the tagged region at a neutral locus of the genome. Our strategy helps generate transgenic cell lines with precision, thereby offering a streamlined and efficient approach to genetic manipulation.

Key words: CRIPR-Cas9, guide RNA (gRNA), RMCE (FLP), AAVS1, Homologous Recombination.






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.